ArticleClinical immunology (Orlando, Fla.)2016

Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40.

Junxiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.